Dr. Ahmed H. Eldefrawy, MD

Dr. Eldefrawy practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Eldefrawy's NPI, 1730449216, was assigned on May 18, 2012. Dr. Eldefrawy graduated from University of Alexandria Faculty of Medicine in 2006. Dr. Eldefrawy holds Florida license ME145621.

Dr. Eldefrawy's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Eldefrawy's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Eldefrawy is also affiliated with Baptist Health Mariners Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Eldefrawy to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eldefrawy practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Eldefrawy's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Eldefrawy is board certified in urology by the American Board of Urology. Dmand AI has Dr. Eldefrawy's licenses on file in 4 states: Florida, Arizona, California and Oklahoma.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Eldefrawy treats.

CMS data shows 879 Medicare services from Dr. Eldefrawy across 11 procedure codes in 2024, for 310 Medicare patients. Medicare paid $54,998 for them.

CMS counts 310 Medicare patients who saw Dr. Eldefrawy in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eldefrawy's median patient age at 70, with 23% women.

In 2024, Dr. Eldefrawy wrote 15 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $57 in total drug cost. In 2022, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Eldefrawy for performance year 2024, reported through an alternative payment model (APM). Dr. Eldefrawy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eldefrawy as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Eldefrawy, more than 67% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Eldefrawy, published from 2009 to 2024. 2011 was the busiest year, with 6. The most frequent topics are Kidney Neoplasms, Nephrectomy and Carcinoma, Renal Cell. Dr. Eldefrawy has published most often in Urology. Dr. Eldefrawy's most frequent co-authors are Murugesan Manoharan, MD, Mark S. Soloway, MD and Sunil H. Patel, MD.

CMS Open Payments shows 80 general payments to Dr. Eldefrawy from 14 drug and device companies from 2016 to 2025. Education make up the largest share, 77% of the total. Intuitive Surgical, Inc. paid the most, $43,967.

Dr. Eldefrawy graduated from University of Alexandria Faculty of Medicine in 2006.

Dr. Eldefrawy is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.